Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV003738057 | SCV004565046 | pathogenic | not provided | 2023-04-28 | criteria provided, single submitter | clinical testing | The VWF c.1239dup; p.Leu414AlafsTer15 variant (rs770203987) is reported in the heterozygous state in individuals with VWD type 1 and in the compound heterozygous state in individuals with VWD type 3 (Veyradier 2016). This variant is also reported in ClinVar (Variation ID: 1065243) and is only observed on two alleles in the Genome Aggregation Database, indicating it is not a common polymorphism. This variant causes a frameshift by inserting a single nucleotide, so it is predicted to result in a truncated protein or mRNA subject to nonsense-mediated decay. Based on available information, this variant is considered to be pathogenic. References: Veyradier A et al. A Laboratory Phenotype/Genotype Correlation of 1167 French Patients From 670 Families With von Willebrand Disease: A New Epidemiologic Picture. Medicine (Baltimore). 2016 Mar;95(11):e3038. PMID: 26986123. |
Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, |
RCV001787161 | SCV001572632 | pathogenic | von Willebrand disease type 3 | 2021-04-12 | no assertion criteria provided | clinical testing |